scispace - formally typeset
L

Li Li

Researcher at University of Electronic Science and Technology of China

Publications -  16
Citations -  850

Li Li is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: PI3K/AKT/mTOR pathway & Signal transduction. The author has an hindex of 11, co-authored 16 publications receiving 566 citations.

Papers
More filters
Journal ArticleDOI

Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.

TL;DR: The roles of Notch signaling pathway in tumor metastasis and its regulatory mechanisms are summarized and the current treatment strategies targeting Notch signal pathway are discussed.
Journal ArticleDOI

Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo

TL;DR: Cav-1 is mechanosensitive to LSS exposure, and its activation-induced PI3K/Akt/mTOR signaling promotes motility, invadopodia formation and metastasis of breast carcinoma MDA-MB-231 cells, and Cav-1 knockdown significantly suppressed tumor colonization in the lungs and distant metastases in animal models.
Journal ArticleDOI

Notch-1 signaling promotes the malignant features of human breast cancer through NF-κB activation.

TL;DR: It is demonstrated that activation of Notch-1 signaling pathway promoted the malignant behaviors of MDA-MB-231 cells such as increased cell proliferation, colony formation, adhesion, migration, and invasion, and inhibited apoptosis; whereas deactivation of this signaling pathway led to the reversal of the aforementioned malignant cellular behaviors.
Journal ArticleDOI

Ti2O3 Nanoparticles with Ti3+ Sites toward Efficient NH3 Electrosynthesis under Ambient Conditions.

TL;DR: Ti2O3 nanoparticles are proposed as a pure Ti3+ system that performs efficiently toward NH3 electrosynthesis under ambient conditions and significantly lowered the overpotential of the potential-determining step.
Journal ArticleDOI

Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy.

TL;DR: F folate (FA) receptor targeted magnetic-mesoporous silica nanoparticles for the codelivery of VEGF shRNA and doxorubicin (DOX) (denoted as M-MSN(DOX)/PEI-FA/VEGF shRNA) provided a potential strategy to treat cancer by a singular nanoparticle delivery system.